Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Applied Bionics and Biomechanics
|
July 11, 2022
Evidence Summary of Temperature Management for Comatose Patients after Cardiopulmonary Resuscitation in ICUs
Zhuo Yang, Ting Ni, Yan Yang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
August 6, 2019
<i>Scolopendra subspinipes mutilans L. Koch</i> Ameliorates Rheumatic Heart Disease by Affecting Relative Percentages of CD4<sup>+</sup>CD25<sup>+</sup>FoxP3 Treg and CD4<sup>+</sup>IL17 T Cells
Tiechao Jiang, Qini Zhao, Hongyan Sun, et al.
Journal of Medicinal Chemistry
|
September 30, 2024
Selective and Orally Bioavailable c-Met PROTACs for the Treatment of c-Met-Addicted Cancer
Shilong Ying, Hongli Chi, Xiaoqiu Wu, et al.
Journal of the American Chemical Society
|
December 11, 2025
pH-Isomerizable Acylhydrazone-Based Ionizable Lipids for Spleen-Targeted mRNA Vaccines
Xuqian Deng, Yan Li, Xiaolan Zhu, et al.
Journal of the American Chemical Society
|
January 22, 2024
Tunable Multivalent Aptamer-Based DNA Nanostructures To Regulate Multiheteroreceptor-Mediated Tumor Recognition
Xiaoxue Hu, Hongli Chi, Xiaoyi Fu, et al.
Angewandte Chemie (International Ed. in English)
|
October 15, 2024
Programmable Circular Multivalent Nanobody-Targeting Chimeras (mNbTACs) for Multireceptor-Mediated Protein Degradation and Targeted Drug Delivery
Shiqi Jiang, Xinru Lv, Zhenlin Ouyang, et al.
Journal of the American Chemical Society
|
December 4, 2024
Programmable Circular Multispecific Aptamer-Drug Engager to Broadly Boost Antitumor Immunity
Jinling Chen, Hongli Chi, Chao Wang, et al.
Angewandte Chemie (International Ed. in English)
|
July 20, 2023
Stimuli-Responsive PROTACs for Controlled Protein Degradation
Keli An, Xuqian Deng, Hongli Chi, et al.
Journal of the American Chemical Society
|
April 13, 2026
Dual-Targeting Multivalent Aptamer-Drug Hybrids for Synergistic Cancer Immunotherapy
Hongli Chi, Yanlin Du, Wei Lv, et al.
Nature Biomedical Engineering
|
June 3, 2026
Modular nucleic acid-based construct for delivery of immunostimulatory agonists and oncogene-silencing oligonucleotides in tumours
Hongli Chi, Keli An, Jiaxuan He, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Applied Bionics and Biomechanics
|
July 11, 2022
Evidence Summary of Temperature Management for Comatose Patients after Cardiopulmonary Resuscitation in ICUs
Zhuo Yang, Ting Ni, Yan Yang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
August 6, 2019
<i>Scolopendra subspinipes mutilans L. Koch</i> Ameliorates Rheumatic Heart Disease by Affecting Relative Percentages of CD4<sup>+</sup>CD25<sup>+</sup>FoxP3 Treg and CD4<sup>+</sup>IL17 T Cells
Tiechao Jiang, Qini Zhao, Hongyan Sun, et al.
Journal of Medicinal Chemistry
|
September 30, 2024
Selective and Orally Bioavailable c-Met PROTACs for the Treatment of c-Met-Addicted Cancer
Shilong Ying, Hongli Chi, Xiaoqiu Wu, et al.
Journal of the American Chemical Society
|
December 11, 2025
pH-Isomerizable Acylhydrazone-Based Ionizable Lipids for Spleen-Targeted mRNA Vaccines
Xuqian Deng, Yan Li, Xiaolan Zhu, et al.
Journal of the American Chemical Society
|
January 22, 2024
Tunable Multivalent Aptamer-Based DNA Nanostructures To Regulate Multiheteroreceptor-Mediated Tumor Recognition
Xiaoxue Hu, Hongli Chi, Xiaoyi Fu, et al.
Angewandte Chemie (International Ed. in English)
|
October 15, 2024
Programmable Circular Multivalent Nanobody-Targeting Chimeras (mNbTACs) for Multireceptor-Mediated Protein Degradation and Targeted Drug Delivery
Shiqi Jiang, Xinru Lv, Zhenlin Ouyang, et al.
Journal of the American Chemical Society
|
December 4, 2024
Programmable Circular Multispecific Aptamer-Drug Engager to Broadly Boost Antitumor Immunity
Jinling Chen, Hongli Chi, Chao Wang, et al.
Angewandte Chemie (International Ed. in English)
|
July 20, 2023
Stimuli-Responsive PROTACs for Controlled Protein Degradation
Keli An, Xuqian Deng, Hongli Chi, et al.
Journal of the American Chemical Society
|
April 13, 2026
Dual-Targeting Multivalent Aptamer-Drug Hybrids for Synergistic Cancer Immunotherapy
Hongli Chi, Yanlin Du, Wei Lv, et al.
Nature Biomedical Engineering
|
June 3, 2026
Modular nucleic acid-based construct for delivery of immunostimulatory agonists and oncogene-silencing oligonucleotides in tumours
Hongli Chi, Keli An, Jiaxuan He, et al.
Page
of 1